Literature DB >> 3723156

Recovery from transverse myelitis of systemic lupus erythematosus with steroid therapy.

C A Zerbini, T S Fidelix, G D Rabello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3723156     DOI： 10.1007/bf00314433

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Myelopathy in systemic lupus erythematosus.

Authors:  A S Penn; A J Rowan
Journal:  Arch Neurol       Date:  1968-04

2.  Transverse myelitis with systemic lupus erythematosus.

Authors:  I Scharf; M Nahir; J Hemli
Journal:  J Neurol       Date:  1977-06-13       Impact factor: 4.849

3.  Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus.

Authors:  R W Warren; D W Kredich
Journal:  Arthritis Rheum       Date:  1984-09

4.  Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature.

Authors:  A A Andrianakos; J Duffy; M Suzuki; J T Sharp
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

5.  Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.

Authors:  P C Dowling; V V Bosch; S D Cook
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910

6.  Central nervous system involvement in childhood systemic lupus erythematosus.

Authors:  C L Yancey; R A Doughty; B H Athreya
Journal:  Arthritis Rheum       Date:  1981-11
  6 in total
  5 in total

1.  Lupus or syphilis? That is the question!

Authors:  Joana Azevedo Duarte; Celia Coelho Henriques; Carolina Sousa; José Delgado Alves
Journal:  BMJ Case Rep       Date:  2015-06-04

Review 2.  Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Authors:  B Kovacs; T L Lafferty; L H Brent; R J DeHoratius
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

3.  Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment.

Authors:  V Harisdangkul; D Doorenbos; S H Subramony
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

4.  Central nervous system lupus: concomitant occurrence of myelopathy and cognitive dysfunction.

Authors:  H D Stahl; T H Ettlin; A Plohmann; E W Radü; J Müller-Brand; U Steiger; A Tyndall
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

5.  Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.

Authors:  G Valesini; R Priori; A Francia; G Balestrieri; A Tincani; P Airo; R Cattaneo; A Zambruni; B Troianello; M Chofflon
Journal:  Springer Semin Immunopathol       Date:  1994
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.